1 October 2004 in Clinical Orthopaedics and Related Research
The use of antibiotic-loaded bone cement is an accepted treatment method for infected joint arthroplasties. It is helpful to separate the use of antibiotic-loaded bone cement as a method of prophylaxis as compared with the treatment of an established infection. A low dose of antibiotic-loaded bone cement (≤ 1 g of antibiotic per batch of cement) should be used for prophylaxis, and high-dose antibiotic-loaded bone cement (> 1 g antibiotic per batch of cement) is indicated for treatment. The only commercially available antibiotic-loaded bone cement products are low dose, with the use of tobramycin or gentamicin as an antibiotic selection. High-dose antibiotic-loaded bone cement requires hand mixing by the surgeon to facilitate the use of high dosages and choices of multiple antibiotics. Treatment of infected hip and knee arthroplasties with high-dose antibiotic-loaded bone cement is aided by the use of spacers of various shapes and sizes. These spacers, whether they are static or articulating (mobile), are meant to provide local delivery of antibiotics, stabilization of soft tissues, facilitation of an easier reimplantation, and improved clinical outcomes.
1 December 1999 in Journal of Bone and Joint Surgery
Background:Pelvic discontinuity is a distinct form of bone loss, occurring in association with total hip arthroplasty, in which the superior aspect of the pelvis is separated from the inferior aspect because of bone loss or a fracture through the acetabulum. The purpose of this study was to
1 August 2005 in Clinical Orthopaedics and Related Research
The primary benefit achieved with local antibiotic delivery vehicles is the ability to obtain extremely high levels of local antibiotics without increasing systemic toxicity. Antibiotic-loaded bone cement represents the current standard as an antibiotic delivery vehicle in orthopaedic surgery. Biodegradable alternatives to antibiotic-loaded bone cement also are being used clinically and there are many new products in the active stages of development. These alternatives can be categorized as bone graft, bone graft substitutes or extenders, natural polymers (protein-based products), and synthetic polymers. Composite biomaterials that simultaneously provide the functions of variable antibiotic delivery patterns and also contribute to the process of bone regeneration represent the most ideal class of local antibiotic delivery vehicles. High concentrations of certain antibiotics have been shown to affect the process of normal bone regeneration adversely in a dose dependent response. Considerable investigation still is required to determine the proper use of locally administered antibiotics to negotiate the balance between eradicating infection without excessively inhibiting the processes of bone regeneration.
1 December 2004 in Clinical Orthopaedics and Related Research
Modular acetabular augments were implanted in 16 patients (16 hips) for support of an uncemented hemispheric acetabular component during revision acetabular reconstruction. Based on the classification of Paprosky, acetabular bone defects were classified as 2A in one hip, 2B in three hips, 2C in one hip, 3A in five hips, and 3B in six hips. Preoperatively, the prosthetic femoral head centers were located at a mean horizontal distance of 18.6 mm (range, −3-46 mm), and a mean vertical distance of 27.6 mm (range, −16-52 mm) from the approximate femoral head center. Postoperatively, the prosthetic femoral head centers were located at a mean horizontal distance of 10.4 mm (range, 1-25 mm), and a mean vertical distance of 7.4 mm (range, −15-25 mm). At final followup, no implant had evidence of migration or loosening. At early clinical followup, this modular acetabular augment system seems helpful in acetabular reconstructions that cannot be treated with an uncemented hemispheric cup that would have required other forms of treatment such as structural allografts, acetabular cages, bilobed acetabular components, or custom acetabular components. Longer term followup is required to determine whether there are untoward effects of using a modular acetabular reconstructive system.
1 February 2015 in Journal of Bone and Joint Surgery
C results of porous tibial cone implantation. Methods: Sixty-six porous tantalum tibial cones (sixty-three patients) were reviewed at a mean follow-up time of seventy months (range, sixty to 106 months). According to the Anderson Orthopaedic Research Institute bone defect classification, twenty-four knees had a Type-3 defect, twenty-five knees had a Type-2B defect, and seventeen knees had a Type-2A defect. Results: The mean age at the time of the index revision was sixty-seven years (range, forty-one to eighty-three years), and 57% of patients were female. The mean American Society of Anesthesiologists Physical Status was 2.4 (range, 2 to 3), and the mean body mass index was 33 kg/m2 (range, 25 to 53 kg/m2). Fifteen patients (24%) were on immunosuppressant medications, and eight patients (13%) were current smokers. The patients underwent a mean number of 3.4 prior knee surgical procedures (range, one to twenty procedures), and 49% of patients (thirty-one patients) had a history of periprosthetic infection. The mean Knee Society Scores improved significantly from 55 points preoperatively (range, 4 to 97 points) to 80 points (range, 28 to 100 points) at the time of the latest follow-up (p < 0.0001). One patient had progressive radiolucencies about the tibial stem and cone on radiographs. One patient had complete radiolucencies about the tibial cone, concerning for fibrous ingrowth. Three other cones were revised: one for infection, one for aseptic loosening, and one for periprosthetic fracture. Revision-free survival of the tibial cone component was >95% at the time of the latest follow-up. Conclusions: Porous tantalum tibial cones offer a promising management option for severe tibial bone loss. At the intermediate-term follow-up (five to nine years), porous tantalum tibial cones had durable clinical results and radiographic fixation. The biologic ingrowth of these implants offers the potential for successful long-term structural support in complex knee reconstruction. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence....
1 June 2011 in Journal of Bone and Joint Surgery
Of this study was to determine the results of a novel surgical technique in which readily available synthetic mesh is used for patellar tendon reconstruction. Methods: We retrospectively reviewed thirteen consecutive patients who underwent extensor mechanism reconstruction for subacute or chronic patellar tendon disruption following total knee arthroplasty at an average age of sixty years (range, thirty-seven to seventy-seven years). Five patients had already been treated unsuccessfully with an allograft extensor mechanism reconstruction and eight had a prior revision knee arthroplasty. The surgical technique included use of a knitted monofilament polypropylene graft to reconstruct the patellar tendon and to facilitate fixation of adjacent host tissue into the graft. Follow-up was available for all patients at a mean of forty-two months (range, eleven to 118 months). Results: Three patients had evidence of failure of the graft reconstruction, all within six months. One patient with previous sepsis had recurrent infection and was treated with a knee arthrodesis. The remaining nine patients all demonstrated an extensor lag of no greater than 10° and have had no loss of extension at the time of final follow-up. Knee flexion was maintained in all patients (a mean of 103° preoperatively versus a mean of 107° postoperatively). The mean Knee Society scores for pain and function improved significantly (p < 0.01). Synthetic mesh was significantly less expensive than allograft for this reconstruction. Conclusions: The use of synthetic mesh to reconstruct a disrupted patellar tendon is a straightforward surgical procedure that was successful and durable in the majority of patients in our series. Compared with the use of an allograft, this technique eliminates the possibility of disease transmission and may be more cost-effective. No complications unique to the synthetic mesh were observed. Level of Evidence: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence. On October 17, 2017, this article was updated from its original format to make use of newer inline video display technology. In the online version of the article, videos can now be accessed where they are cited in the text, thereby enhancing user experience. The text has been altered slightly to change the phrase “(See Video 1 in Appendix)” to an in-text reference to each video....